Literature DB >> 33591050

Generalizability of Subgroup Effects.

Marissa J Seamans1, Hwanhee Hong2, Benjamin Ackerman3, Ian Schmid4, Elizabeth A Stuart3,4,5.   

Abstract

Generalizability methods are increasingly used to make inferences about the effect of interventions in target populations using a study sample. Most existing methods to generalize effects from sample to population rely on the assumption that subgroup-specific effects generalize directly. However, researchers may be concerned that in fact subgroup-specific effects differ between sample and population. In this brief report, we explore the generalizability of subgroup effects. First, we derive the bias in the sample average treatment effect estimator as an estimate of the population average treatment effect when subgroup effects in the sample do not directly generalize. Next, we present a Monte Carlo simulation to explore bias due to unmeasured heterogeneity of subgroup effects across sample and population. Finally, we examine the potential for bias in an illustrative data example. Understanding the generalizability of subgroup effects may lead to increased use of these methods for making externally valid inferences of treatment effects using a study sample.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33591050      PMCID: PMC8012217          DOI: 10.1097/EDE.0000000000001329

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.860


  7 in total

1.  Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Authors:  Ryoko Susukida; Rosa M Crum; Cyrus Ebnesajjad; Elizabeth A Stuart; Ramin Mojtabai
Journal:  Addiction       Date:  2017-03-16       Impact factor: 6.526

2.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

3.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

4.  Assessing methods for generalizing experimental impact estimates to target populations.

Authors:  Holger L Kern; Elizabeth A Stuart; Jennifer Hill; Donald P Green
Journal:  J Res Educ Eff       Date:  2016-01-14

5.  Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

Review 6.  INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary).

Authors:  J Stamler; P Elliott; B Dennis; A R Dyer; H Kesteloot; K Liu; H Ueshima; B F Zhou
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

Review 7.  Generalizing Study Results: A Potential Outcomes Perspective.

Authors:  Catherine R Lesko; Ashley L Buchanan; Daniel Westreich; Jessie K Edwards; Michael G Hudgens; Stephen R Cole
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.